- Todos > Quality and Safety: Medicines > Quality Assurance
- Todos > WHO Prequalification of Medical Products > WHO-UNICEF-UN Project
- Palabras clave > Good Practices for Pharmaceutical Quality Control Laboratories (GPCL)
- Palabras clave > Good Practices in Quality Control (GPQC)
- Palabras clave > international harmonization of laboratory practices
- Palabras clave > laboratory quality of medicines
- Palabras clave > quality control
- Palabras clave > quality control laboratories
- Palabras clave > quality standards
(2010; 49 pages) [French] [Portuguese] [Spanish] [Thai]
The WHO Expert Committee on Specifications for Pharmaceutical Products adopted in 1999 the guidelines entitled WHO Good practices for national pharmaceutical control laboratories, which were published as Annex 3 of the WHO Technical Report Series, No. 902, 2002. As the other guidelines related to laboratory quality assurance have been updated and subsequent inspections for the compliance with the guidelines on good practices for national pharmaceutical control laboratories indicated that some sections were in need of improvement and clarification, it was considered necessary to prepare a revised text. These guidelines provide advice on the quality management system within which the analysis of active pharmaceutical ingredients (APIs), excipients and pharmaceutical products should be performed to demonstrate that reliable results are obtained.
Compliance with the recommendations provided in these guidelines will help promote international harmonization of laboratory practices and will facilitate cooperation among laboratories and mutual recognition of results. Special attention should be given to ensure the correct and efficient functioning of the laboratory. Planning and future budgets should ensure that the necessary resources are available inter alia for the maintenance of the laboratory, as well as for an appropriate infrastructure and energy supply. Means and procedures should be in place (in case of possible supply problems) to ensure that the laboratory can continue its activities.
These guidelines are applicable to any pharmaceutical quality control laboratory, be it national, commercial or nongovernmental. However, they do not include guidance for those laboratories involved in the testing of biological products, e.g. vaccines and blood products. Separate guidance for such laboratories is available.
These guidelines are consistent with the requirements of the WHO guidelines for good manufacturing practices and with the requirements of the International Standard ISO/IEC 17025:2005, and provide detailed guidance for laboratories performing quality control of medicines. The guidance specific to microbiology laboratories can be found in the draft working document WHO guideline on good practices for pharmaceutical microbiology laboratories (reference QAS/09.297)...